Skip to main content
Pain is typically ranked by both patients and physicians as the most important symptom of psoriatic arthritis (PsA) to assess and treat. Although the predominant concept of the etiology of pain in PsA is that of inflammation in peripheral joints, entheses, and bone signaling through peripheral nociceptive fibers, perceived as pain in the central nervous system, it is actually more complex than that. The ability of a treatment to ameliorate
Biologics for JIA? Not So Fast, Say Insurers
  • MedPage Today
It's not a simple matter to prescribe tumor necrosis factor (TNF) inhibitors for patients with juvenile idiopathic arthritis (JIA), at least those with insurance, a single-center study found. Among 54 patients seen at Boston Children's Hospital for newly diagnosed JIA in 2018-2019, their insurers required prior authorization for all but one, according to researchers there led by Jordan E. Roberts, MD.
Mayo Clinic Proceedings reports the results of a retrospective, cross-sectional of patients with HFE hemochromatosis showing that advanced hepatic fibrosis is primarily seen in those with arthritis due to HFE hemochromatosis. 
FDA approved 1st drug for kids with COVID-19. Veklury (remdesivir) get an expanded indication in Peds >28days old &am

Dr. John Cush RheumNow

4 years 5 months ago
FDA approved 1st drug for kids with COVID-19. Veklury (remdesivir) get an expanded indication in Peds >28days old & wt > 3 kg who has SARS-CoV-2 & are Hospitalized, or Not hospitalized & at high risk for severe COVID-19 or death https://t.co/7Hn4CwKjxv
COVID-19 Vaccination Uptake and Perceptions in Rheumatic Patients

Putman et al has reported vaccine survey results from

Dr. John Cush RheumNow

4 years 5 months ago
COVID-19 Vaccination Uptake and Perceptions in Rheumatic Patients Putman et al has reported vaccine survey results from the C19-GRA in Lancet Rheumatology showing the uptake and vaccine hesitancy among people with rheumatic diseases (RMD). https://t.co/sqsOHGThzV https://t.co/zeZrlDeQ9Z
One centers experience with a combined Rheum-Derm Clinic. Among 151 psoriasis patients with suspicious musculoskeletal c

Dr. John Cush RheumNow

4 years 5 months ago
One centers experience with a combined Rheum-Derm Clinic. Among 151 psoriasis patients with suspicious musculoskeletal complaints, 85% were dx w/ PsA - 62% of these PsA was 1st diagnosed. https://t.co/RcQrWaXTWj
QD Clinic - PsA lessons and cases from the Rheumatology clinic.

Distinguishing Psoriatic arthritis from Erosive Osteoar

Dr. John Cush RheumNow

4 years 5 months ago
QD Clinic - PsA lessons and cases from the Rheumatology clinic. Distinguishing Psoriatic arthritis from Erosive Osteoarthritis can be difficult https://t.co/UCcCMqUL2d https://t.co/zLkfBYI4Cm
Open label, RCT compared triple DMARD Rx adding either LEF (MLH) or SSZ (MSH) to MTX+HCQ in 136 RA pts. Both were equal

Dr. John Cush RheumNow

4 years 5 months ago
Open label, RCT compared triple DMARD Rx adding either LEF (MLH) or SSZ (MSH) to MTX+HCQ in 136 RA pts. Both were equally effective (non-inferior), 61.7% & 64.7% patients (p = 0.8) at wk 24. AE were also equal (15 vs 21 AE). https://t.co/ZucrYKuNms
Mark your calendars for our next Tuesday Night Rheumatology on 4/26 at 7pm!

Speakers will include:

Dr. Eric Ruderman
D

Dr. John Cush RheumNow

4 years 5 months ago
Mark your calendars for our next Tuesday Night Rheumatology on 4/26 at 7pm! Speakers will include: Dr. Eric Ruderman Dr. Arthur Kavanaugh Dr. David Liew Dr. Jack Cush https://t.co/by1xtmPSZ0 You can also find us LIVE on YouTube, Twitter, and Facebook. https://t.co/o633KHx81b
Global Rheumatology Therapeutics (drug) Market size is estimated to be $29.37 billion (USD) in 2022, and is projected to

Dr. John Cush RheumNow

4 years 5 months ago
Global Rheumatology Therapeutics (drug) Market size is estimated to be $29.37 billion (USD) in 2022, and is projected to grow to $40.13 billion by 2027. https://t.co/JDzkYFENFc
ICYMI: Axial Disease in Psoriatic Arthritis

Inflammatory involvement of the axial skeleton and sacroiliac joints occur

Dr. John Cush RheumNow

4 years 5 months ago
ICYMI: Axial Disease in Psoriatic Arthritis Inflammatory involvement of the axial skeleton and sacroiliac joints occurs, on average, in 40-50% of patients with psoriatic arthritis (PsA). https://t.co/QKtpSPDz5V https://t.co/ROz5o9OTyZ
QD clinic - PsA Lessons from Patients

Enthesitis in a 14 yr.old - management and evolutionary possibilities

https://t.

Dr. John Cush RheumNow

4 years 5 months ago
QD clinic - PsA Lessons from Patients Enthesitis in a 14 yr.old - management and evolutionary possibilities https://t.co/MtgoDXJ7EF https://t.co/sTFyySF4vl
Did you missed this past Tuesday Night Rheumatology? We have the playback available now.

The PsA Expert panelists inclu

Dr. John Cush RheumNow

4 years 5 months ago
Did you missed this past Tuesday Night Rheumatology? We have the playback available now. The PsA Expert panelists included: Dr. Dafna Gladman Dr. Joseph Merola, Dr. Peter Nash, Dr. Christopher Ritchlin, Dr. Jose Scher and Dr. Jack Cush. https://t.co/u5lt2uDoGK https://t.co/lOmN4OoGLi
COVID-19 Vaccination Uptake and Perceptions in Rheumatic Patients

Putman et al has reported vaccine survey results from

Dr. John Cush RheumNow

4 years 5 months ago
COVID-19 Vaccination Uptake and Perceptions in Rheumatic Patients Putman et al has reported vaccine survey results from the C19-GRA in Lancet Rheumatology showing the uptake and vaccine hesitancy among people with rheumatic diseases (RMD). https://t.co/fIHAhpvVho https://t.co/6tFbQd0vJQ
×